We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 376

Ohio Attorney General Sues Pharmaceutical Companies Over Opioid Marketing - Yet Another Sign of Government Focus on Recovering Financial Cost of Opioid Epidemic
  • Pietragallo Gordon Alfano Bosick & Raspanti LLP
  • USA
  • June 9 2017

Last week, Ohio Attorney General Mike DeWine filed a lawsuit against multiple pharmaceutical companies, including Purdue, Teva, Johnson & Johnson

'Tis the season to not give kickbacks
  • Bricker & Eckler LLP
  • USA
  • December 19 2011

The Department of Justice announced two cases involving kickbacks in the last two weeks, one was a criminal case involving a Miami, Florida-based mental health care provider, American Therapeutic Corporation, and the second was a civil settlement with medical device manufacturer Medtronic Inc.

New indictment of in-house counsel indicates enhanced efforts to hold corporate executives accountable for food and drug law violations
  • Fish & Richardson PC
  • USA
  • November 15 2010

This year, both the Food and Drug Administration (FDA) and Department of Justice have repeatedly signaled to the pharmaceutical and medical device industries that they should expect an increase in the criminal prosecution of individuals for alleged violations of the food and drug laws, with the stated goals of increasing deterrence and greater compliance.

Virginia A. Gibson
  • Hogan Lovells

Kathleen P. Rubinstein
  • Baker & Hostetler LLP

Saber W. VanDetta
  • Squire Patton Boggs

Jennifer Orr Mitchell
  • Dinsmore & Shohl LLP